Abel Suárez‐Fueyo

机构：AbbVie (United States) · ORCID：0000-0002-8696-0197

发表论文 36 篇 · 总被引 2025 次 · h-index 18

代表论文

• Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective (2017 · Trends in Molecular Medicine · 被引 491)
• The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections (2020 · Cell Reports · 被引 162)
• T cells and autoimmune kidney disease (2017 · Nature Reviews Nephrology · 被引 137)
• Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus‐like Disease in MRL / lpr Mice and Experimental Autoimmune Encephalomyelitis (2019 · Arthritis & Rheumatology · 被引 111)
• SLAMF6 as a Regulator of Exhausted CD8+ T Cells in Cancer (2019 · Cancer Immunology Research · 被引 69)
• The Regulatory Subunit PPP2R2A of PP2A Enhances Th1 and Th17 Differentiation through Activation of the GEF-H1/RhoA/ROCK Signaling Pathway (2021 · The Journal of Immunology · 被引 41)